<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04598555</url>
  </required_header>
  <id_info>
    <org_study_id>CLI-01535AA0-01</org_study_id>
    <nct_id>NCT04598555</nct_id>
  </id_info>
  <brief_title>Study on Patterns of Care in Mild Asthmatic Patients</brief_title>
  <acronym>PRIME</acronym>
  <official_title>A Multi-centre Multi-country Prospective obseRvatIonal Study on Patterns of Care of Mild Asthmatic patiEnts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chiesi Farmaceutici S.p.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chiesi Farmaceutici S.p.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The PRIME study is an observational, Real World Evidence study designed to collect the type&#xD;
      of treatments that are currently prescribed to patients with mild asthma and to collect&#xD;
      relevant clinical data that could reflect the control of the disease over a 6-month&#xD;
      observational period according to the standard clinical practice.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Outpatients attending the hospital clinics/study centres will be recruited. Patients with&#xD;
      mild asthma treated by Step 1 or step 2 treatments according to GINA report will be&#xD;
      recruited. A total of approximately 1200 patients will be enrolled. Patients will be&#xD;
      followed-up during a 6-month observational period according to standard practices.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 25, 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To describe the real-world patterns of treatment of subjects with mild asthma during a 6-month observational period.</measure>
    <time_frame>6-months period</time_frame>
    <description>Frequency of asthma treatments for asthma management, regardless the duration:&#xD;
by active substance&#xD;
by drug class&#xD;
distinguishing between &quot;controller&quot; and &quot;reliever&quot; treatments</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To describe the real-world patterns of treatment of subjects with mild asthma during a 6-month observational period.</measure>
    <time_frame>6-months period</time_frame>
    <description>Frequency of subjects experiencing asthma treatment switches, step-ups and step-downs during the observation period, along with the description of pattern of switch (in terms of sequence of treatments over time)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To describe the real-world patterns of treatment of subjects with mild asthma during a 6-month observational period.</measure>
    <time_frame>6-months period</time_frame>
    <description>Frequency of treatment posology, stratified by type of asthma treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To describe the real-world patterns of treatment of subjects with mild asthma during a 6-month observational period.</measure>
    <time_frame>6-months period</time_frame>
    <description>Duration of asthma treatments (in months):&#xD;
overall&#xD;
by drug class (i.e., any switch to drugs within the same class will be considered as a continuation of the treatment) and by active substance (i.e., any dose adaptation will be considered as a continuation of the same drug). This will be adapted according to data availability.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To describe the Socio-demographics data of subjects with mild asthma at enrolment visit</measure>
    <time_frame>At enrolment</time_frame>
    <description>BMI in kg/m^2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the clinical characteristics of subjects with mild asthma at enrolment visit</measure>
    <time_frame>At enrolment</time_frame>
    <description>Lifestyle and smoking habits data description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the Daytime and night-time symptoms of subjects with mild asthma at enrolment visit</measure>
    <time_frame>At enrolment</time_frame>
    <description>Frequency of daytime and night-time symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the Daytime and night-time symptoms of subjects with mild asthma at enrolment visit</measure>
    <time_frame>At enrolment</time_frame>
    <description>Type of daytime and night-time symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the Asthma Diagnosis of subjects with mild asthma at enrolment visit</measure>
    <time_frame>At enrolment</time_frame>
    <description>Time from first Asthma Diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the Asthma Diagnosis of subjects with mild asthma at enrolment visit</measure>
    <time_frame>At enrolment</time_frame>
    <description>Type of diagnosis strategy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the asthma exacerbations of subjects with mild asthma at enrolment visit</measure>
    <time_frame>At enrolment</time_frame>
    <description>Asthma exacerbations history data description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the prior asthma treatment of subjects with mild asthma at enrolment visit</measure>
    <time_frame>At enrolment</time_frame>
    <description>Type of prior Asthma treatments description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the clinical characteristics of subjects with mild asthma at enrolment visit</measure>
    <time_frame>At enrolment</time_frame>
    <description>Skin Prick test data description</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the evolution of lung function parameters (FEV1 (L)) during the 6-month observational period</measure>
    <time_frame>At enrolment and at 6-month</time_frame>
    <description>Spirometry results at enrolment and at 6-month follow-up visit (according to sites' standard practice): measurement of Forced Expiratory Volume in 1 second (FEV1) in L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the evolution of lung function parameters (FEV1 (%)) during the 6-month observational period</measure>
    <time_frame>At enrolment and at 6-month</time_frame>
    <description>Spirometry results at enrolment and at 6-month follow-up visit (according to sites' standard practice): measurement of FEV1 predicted value in %,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the evolution of lung function parameters (FVC (L)) during the 6-month observational period</measure>
    <time_frame>At enrolment and at 6-month</time_frame>
    <description>Spirometry results at enrolment and at 6-month follow-up visit (according to sites' standard practice): Forced Vital Capacity (FVC) in L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the evolution of lung function parameters (FVC (%))during the 6-month observational period</measure>
    <time_frame>At enrolment and at 6-month</time_frame>
    <description>Spirometry results at enrolment and at 6-month follow-up visit (according to sites' standard practice): measurement of FVC % predicted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the evolution of lung function parameters (FEV1/FVC ratio) during the 6-month observational period</measure>
    <time_frame>At enrolment and at 6-month</time_frame>
    <description>Spirometry results at enrolment and at 6-month follow-up visit (according to sites' standard practice): measurement of FEV1/FVC ratio in %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe subjects' level of asthma symptoms control by means of the Asthma Control Test (ACT) during the 6-month observational period</measure>
    <time_frame>At enrolment and at 6-month</time_frame>
    <description>ACT score. ACT is a 5-point scale (for symptoms and activities: 1=all the time to 5= not at all; for asthma control rating: 1=not controlled at all to 5=completely controlled). ACT scores range from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score &gt;19 indicates well-controlled asthma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe subjects' level of asthma symptoms control by means of the Asthma Control Questionnaire (ACQ-5) during the 6-month observational period</measure>
    <time_frame>At enrolment and at 6-month</time_frame>
    <description>ACQ-5 score. ACQ-5 is a 7-point scale (0=no impairment, 6= maximum impairment) and scores range between 0 (totally controlled) and 6 (severely uncontrolled).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the occurrence of asthma exacerbations during the 6-month observational period</measure>
    <time_frame>6-months period</time_frame>
    <description>Number of Asthma exacerbations during the 6-month observational period (seriousness, severity, relatedness to the treatment product, start date and end date (duration will be calculated during data analysis), outcome, action taken with respect to drug and other treatments used to treat exacerbations)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the utilization of healthcare resources in subjects with mild asthma during the 6- month observational period</measure>
    <time_frame>6-months period</time_frame>
    <description>Number of Inward/Day-hospital hospitalizations, emergency room accesses and GP/outpatient specialist visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the utilization of healthcare resources in subjects with mild asthma during the 6- month observational period</measure>
    <time_frame>6-months period</time_frame>
    <description>Number and type of tests and exams per subject</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the utilization of healthcare resources in subjects with mild asthma during the 6- month observational period</measure>
    <time_frame>6-months period</time_frame>
    <description>Duration of Inward/Day-hospital hospitalizations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the subjects' quality of life by means of the Mini Asthma Quality of Life Questionnaire (MiniAQLQ) during the 6-month observational period</measure>
    <time_frame>At enrolment and at 6-month</time_frame>
    <description>MiniAQLQ scores. The MiniAQLQ is a 7-point Likert scale (7 = not impaired at all - 1 = severely impaired) and scores range 1-7, with higher scores indicating better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe the occurrence of adverse drug reactions (ADRs) in subjects with mild asthma during the 6-month observational period.</measure>
    <time_frame>6-month</time_frame>
    <description>Only Adverse Drug Reactions (ADRs) to any asthma medication occurred during the 6-month observational period will be collected</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Asthma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Mild asthma patients treated by step 1 or 2 treatments according to GINA report&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult subject (aged ≥ 18 years) up to 75 years&#xD;
&#xD;
          -  Subject with confirmed asthma diagnosis&#xD;
&#xD;
          -  Subject in treatment for mild asthma with Step 1 or Step 2 according to GINA report&#xD;
&#xD;
          -  Subject with written privacy and study informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject enrolled in experimental (interventional) clinical trials, or receiving&#xD;
             experimental treatments in the prior 3 months&#xD;
&#xD;
          -  Known pregnant or breast-feeding subject&#xD;
&#xD;
          -  Subject unable to understand and autonomously fill in questionnaires&#xD;
&#xD;
          -  Subject unable to use electronic devices to fill in e-diary, or without compatible&#xD;
             electronic devices with access to the Internet&#xD;
&#xD;
          -  Subject who had asthma exacerbation(s) in the past 4 weeks prior to study entry&#xD;
&#xD;
          -  Subject with confirmed Chronic Obstructive Pulmonary Disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Topole, Dr</last_name>
    <role>Study Director</role>
    <affiliation>CHIESI Clinical Program Leader</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chiesi Clinical Trial Info</last_name>
    <phone>+ 39 0521 2791</phone>
    <email>clinicaltrials_info@chiesi.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>DE-008 Lungenarztpraxis Hellersdorf</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jens Driemert</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DE-003 Praxis Pneumologie und Allergologie Dr. Ginko</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Tomasz Ginko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DE-005 Praxis für Pneumologie und Innere Medizin</name>
      <address>
        <city>Fürstenwalde</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Athanasios Xanthopoulos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DE-006 Studieninstitut des Pneumologicums Halle</name>
      <address>
        <city>Halle</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Peter-Uwe Haase</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DE-001 Salvus - Klinische Studien GmbH</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Regina Deckelmann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DE-007 POIS Leipzig GbR</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christian Gessner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DE-004 Fortbildungs- und Studienzentrum Innere Medizin Marburg GbR</name>
      <address>
        <city>Marburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Silke Mronga</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DE-009 Praxis Dr. Jansen</name>
      <address>
        <city>Menden</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Volker Jansen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DE-012 Pneumologisch-Internistische Gemeinschaftspraxis Elisenhof</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Korkut Avsar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DE-010 Studienzentrum Dr. Schlenska</name>
      <address>
        <city>Peine</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christian Schlenska</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DE-002 RespiRatio / Lungenpraxis Schleswig</name>
      <address>
        <city>Schleswig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andreas Deimling</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-028 Fisiopatologia Respiratoria Ospedale Ecclesiastico Miulli</name>
      <address>
        <city>Acquaviva Delle Fonti</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pietro Schino</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-026 SOSD Allergologia A.O.U. Ospedali Riuniti</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Beatrice Bilò</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-005 UO Allergologia Ospedale S.Maria della Speranza</name>
      <address>
        <city>Battipaglia</city>
        <zip>84091</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincenzo Patella, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>IT-019 UOC Pneumologia Ospedale Bellaria</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alberto Rocca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-008 Pneumologia Policlinico Universitario Mater Domini</name>
      <address>
        <city>Catanzaro</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Girolamo Pelaia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-006 SC MAR Univ A.O.U. Ospedali Riuniti Foggia</name>
      <address>
        <city>Foggia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Giulia Scioscia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-001 UOC Pneumologia Fondazione Cà Granda Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Francesco Blasi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-007 Malattie Apparato Respiratorio A.O.U. Modena Policlinico</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Bianca Berghè</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-025 Allergologia e Immunologia clinica Policlinico Casula A.O.U. Cagliari</name>
      <address>
        <city>Monserrato</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stefano Del Giacco</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-012 UOC Clinica Pneumologica A.O. dei Colli P.O. Monaldi</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Andrea Bianco</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-016 SSD Intertiziopatie e Malattie del Polmone A.O.U. San Luigi Gonzaga</name>
      <address>
        <city>Orbassano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fabio Luigi Massimo Ricciardolo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-010 Medicina del Lavoro, Mal.Respiratorie e Tossicologia Azienda Ospedaliera</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nicola Murgia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-013 UO Pneumologia A.O.U. Pisana P.O. Cisanello</name>
      <address>
        <city>Pisa</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Deferico Lorenzo Dente</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-015 UOC Pneumologia Policlinico Univ. A. Gemelli</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Matteo Bonini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-020 UOC Pneumologia A.O.U. Sant'Andrea</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alberto Ricci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-009 Pneumologia Clinica e Interventistica AOU Policlinico Universitario stabilim San Pietro</name>
      <address>
        <city>Sassari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alessandro Fois</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-021 Servizio Pneumologia PTA Ospedale Busacca</name>
      <address>
        <city>Scicli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Enzo Vicenzo Cannata</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-024 Allergologia Casa della Salute</name>
      <address>
        <city>Scilla</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Antonino Musara</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-029 Malattie Respiratorie e Trapianto Polmonare A.O.U. Senese Policlinico Le Scotte</name>
      <address>
        <city>Siena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Elena Bargagli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-017 Pneumologia Riabilitativa ICS Maugeri</name>
      <address>
        <city>Telese Terme</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mauro Maniscalco</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-022 Pneumologia Univ. A.O.U. Città della Salute e della Scienza</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Paolo Solidoro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-003 UO Pneumologia Riabilitativa ICS Maugeri</name>
      <address>
        <city>Tradate</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Dina Visca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IT-018 USD Allergologia AOUI Policlinico Rossi</name>
      <address>
        <city>Verona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gianenrico Senna</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-012 Centrum Medyczne Pratia</name>
      <address>
        <city>Bydgoszcz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Anna Krukowska</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-018 Prywatny Gabinet Ewa Gawrońska-Ukleja</name>
      <address>
        <city>Bydgoszcz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ewa Gawrońska-Ukleja</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-010 M2M Badania Kliniczne</name>
      <address>
        <city>Chorzów</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Szymnon Placzek</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-015 Prywatny gabinet Pulmonologiczny at premises of Amicmed Medical Center</name>
      <address>
        <city>Grudziądz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joanna Nowacka-Apyio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-005 Centrum Medyczne ALL-MED</name>
      <address>
        <city>Kraków</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Grażyna Pulka</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-004 CDT Medicus</name>
      <address>
        <city>Lubin</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Artur Kwaśniewski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-009 Centrum Alergologii Sp. z o. o</name>
      <address>
        <city>Lublin</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Izabela Krupa-Borek</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pl-006 Ppl Ps Magmed</name>
      <address>
        <city>Radom</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Magdalena Napora-Grabowska</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-014 Indywidualna Specjalistyczna Praktyka Lekarska Marzenna Tarnowska-Matusiak</name>
      <address>
        <city>Szczecin</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Lidia Drążewska</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-016 NZOZ Poradnia Chorób Płuc i Alergologii</name>
      <address>
        <city>Słupsk</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Sławomir Garbicz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-003 Praktyka lekarska Marzena Justyna Mierzejewska</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Justyna Mierzejewska</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-011 Lekarze Specjaliści J.Małolepszy i Partnerzy</name>
      <address>
        <city>Wrocław</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Krzysztof Wytrychowski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-001 Poradnia Alergologii i Chorób Płuc, SPZOZ Uniwersytecki Szpital Kliniczny nr 1 im Norberta Barlickiego</name>
      <address>
        <city>Łódź</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Piotr Kuna</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-013 SNZOZ Poradnia Specjalistyczna MedMed, Ul. Brzechwy 7a</name>
      <address>
        <city>Łódź</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kinga Kuczyńska</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PL-017 Gabinet Pulmonologiczny</name>
      <address>
        <city>Łódź</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Beata Janiszewska-Drobińska</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ES-005</name>
      <address>
        <city>Badalona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Albert Reig</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ES-009 Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vicente Plaza Moral</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ES-014 Hospital El Pilar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Pablo Rubinstein Aguñin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ES-002 Hospital Universitario La Princesa</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Carolina Cisneros Serrano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ES-004 'Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Javier Domínguez Ortega</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ES-008 Fundación Jiménez Díaz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Joaquin Sastre Dominguez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ES-010 Hospital Costa del Sol</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>María Pérez Morales</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ES-007 Complejo asistencial Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Esther maria Moreno Rodilla</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ES-11 Hospital Universitario Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Juan Luis García Rivero</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ES-003 Hospital Universitario Dr. Peset</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Eva Martínez Moragon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 12, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2020</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

